Tae Won Kim

9PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Counselling psychologyEpigenetics (incl. genome methylation and epigenomics)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 21, 2026
Vactosertib plus pembrolizumab in patients with non-microsatellite instability-high metastatic colorectal or gastric cancer: a multicenter, phase Ib/IIa study.

|Jul 14, 2026
Physician Consultation Time and Perceived Quality of Outpatient Care for New Cancer Patients in Korea: An Experimental Vignette Survey of the General Public and Physicians.

|May 30, 2026
Dynamics of tumor ecosystems and microbiome in response to neoadjuvant ABFOLFOX treatment in patients with unresectable colorectal cancer with liver metastasis.

|Aug 22, 2025
Whole genome sequencing reveals telomere associated genomic differences between healthy and unhealthy aging in a Korean population.

Ji-Hye Oh, Hyo Jeong Lee, Wonkyung Kim

|Jun 30, 2022
Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07.

Seung Tae Kim, Sun Young Kim, Jeeyun Lee

|Feb 18, 2022
Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability-high/mismatch repair-deficient or POLE-mutated metastatic or unresectable colorectal cancer.

Chung Ryul Oh, Jeong Eun Kim, Yong Sang Hong

Pageof 2

Frequent Collaborators

2 joint publications

Chang Ohk Sung

2 joint publications

Tae Won Kim

1 joint publications

Minsuk Kwon

1 joint publications

Jin Young Kim